Evotec OAI and MelTec form Joint Venture and Enter into a Drug Discovery Service Collaboration
26-Jun-2001 -
Evotec OAI, Hamburg, Germany (EVOTEC BioSystems AG, Neuer Markt: EVT), a supplier of integrated
high-value added biological, chemical and screening services, and MelTec GmbH, a pioneer in topological proteomics, announced today that they have entered into a
collaboration. The agreement involves ...
autoimmune diseases
biotechnology
drug development
+7